TrialAnnals of hematology2026

Long-term follow-up of predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia in the phase 3 COMMODORE trial.

Bin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.